Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
01/01/2009 | US20090004109 Antibodies and Molecules Derived Therefrom that Bind to Steap-1 Proteins |
01/01/2009 | US20090000949 Method And Apparatus Of Concentration And Purification Of Nucleic Acid |
12/31/2008 | WO2009003078A2 Temporal regulation of gene expression by micrornas |
12/31/2008 | WO2009002944A1 Double strand compositions comprising differentially modified strands for use in gene modulation |
12/31/2008 | WO2009002937A2 Methods for isolating long fragment rna from fixed samples |
12/31/2008 | WO2009002932A1 The use of plant glycosyl hydrolases with carbohydrate binding modules to alter plant cell wall composition and structure, or enhance degradation |
12/31/2008 | WO2009002832A2 Inhibitors of ncca-atp channels for therapy |
12/31/2008 | WO2009002607A1 Compositions and methods for identifying transforming and tumor suppressor genes |
12/31/2008 | WO2009002462A1 Pre-mirna loop-modulated target regulation |
12/31/2008 | WO2009002223A1 Method for producing a human hybrid stem cell |
12/31/2008 | WO2009002198A2 Expression cassette, t-dna molecule, plant expression vector, transgenic plant cell as well as their use in the manufacturing of a vaccine |
12/31/2008 | WO2009002193A1 Polypeptides and polynucleotides for artemin and related ligands, and methods of use thereof |
12/31/2008 | WO2009002150A1 Targeted nucleotide exchange with improved modified oligonucleotides |
12/31/2008 | WO2009001939A1 Marker gene for detection of tumor promoter, and method for detection of tumor promoter |
12/31/2008 | WO2009001867A1 Vaccine antigen capable of inducing cross-reacting and neutralizing antibody against high-risk-type human papillomavirus |
12/31/2008 | WO2009001840A1 Anti-prominin-1 antibody having adcc activity or cdc activity |
12/31/2008 | WO2009001743A1 Novel adamts-13 mutant |
12/31/2008 | WO2009001737A1 Improved method of detecting norovirus rna |
12/31/2008 | WO2009001562A1 Compositions and methods of treating cancer |
12/31/2008 | WO2009001555A1 Expression controller of type i interferon |
12/31/2008 | WO2009001398A2 Transgenic containment system through the recoverable inhibition of the germination in transgenic seeds |
12/31/2008 | WO2009001392A1 Gene codifying for ambra 1 protein which regulates autophagv and the development of the central nervous system |
12/31/2008 | WO2009001315A2 Use of a class of genes encoding lysophospholipid acyl transferases for application in agriculture, biotechnology, and medicine |
12/31/2008 | WO2009001159A1 Method for enhancing the cleavage activity of i-crei derived meganucleases |
12/31/2008 | WO2009001141A1 Detection of cell surface binding molecules using a phage display blocking assay |
12/31/2008 | WO2009001135A2 Combinatorial libraries and related methods |
12/31/2008 | WO2009001058A1 Modified chondroitinase polypeptides |
12/31/2008 | WO2009001010A2 Device for the lysis of microorganisms present in an environmental or clinical sample and the extraction of nucleic acids from said microorganisms for analysis |
12/31/2008 | WO2009000894A1 Anti-vpac1 antibodies and their uses |
12/31/2008 | WO2009000891A2 Linear expression constructs for production of influenza virus particles |
12/31/2008 | WO2009000876A1 Yield enhancement in plants by modulation of maize rp120-rna binding protein homolog (ebna2-coact) |
12/31/2008 | WO2009000848A1 Yield enhancement in plants by modulation of zmago1 |
12/31/2008 | WO2009000789A1 Yield enhancement in plants by modulation of maize myb-ada2 gene |
12/31/2008 | WO2009000736A2 F. oxysporum f.sp. melonis race 1,2-resistant melons |
12/31/2008 | WO2009000733A1 Fortification of plants with folates by metabolic engineering |
12/31/2008 | WO2009000557A1 Starches with high amylose content and improved processing properties |
12/31/2008 | WO2009000539A1 Modulation of production of retroviruses by apobec4 |
12/31/2008 | WO2009000538A1 Trimeric death ligands with enhanced activity (tenascin) |
12/31/2008 | WO2009000432A1 Translation control elements for plastid transformation |
12/31/2008 | WO2009000281A1 Methods for directional cloning of amplified nucleic acids and uses thereof |
12/31/2008 | WO2009000099A2 Methods of modifying antibodies, and modified antibodies with improved functional properties |
12/31/2008 | WO2009000098A2 Sequence based engineering and optimization of single chain antibodies |
12/31/2008 | WO2009000066A1 Vaccine against clostridium perfringens |
12/31/2008 | WO2009000063A1 Inducible/regulated gene expression systεm in e coli |
12/31/2008 | WO2009000017A1 Peptides as antimicrobial agents towards campylobacter spp |
12/31/2008 | WO2008141096A3 Nucleic acids for inducing expression of transcripts and proteins and methods for making and using them |
12/31/2008 | WO2008140766A3 Highly active soybean promoters and uses thereof |
12/31/2008 | WO2008138131B1 Bone targeted alkaline phosphatase, kits and methods of use thereof |
12/31/2008 | WO2008138131A4 Bone targeted alkaline phosphatase, kits and methods of use thereof |
12/31/2008 | WO2008137776A3 Rna interference mediated inhibition of cyclic nucleotide type 4 phosphodiesterase (pde4b) gene expression using short interfering nucleic acid (sina) |
12/31/2008 | WO2008135603A3 Over-expression of maize cox viia subunit for enhanced yield |
12/31/2008 | WO2008135047A3 Controllable promoters for use in fission yeast |
12/31/2008 | WO2008134640A3 Cells expressing chimeric ns4a proteins of hcv and their use in assays |
12/31/2008 | WO2008132568A3 Fusion proteins binding to growth factors |
12/31/2008 | WO2008129146A3 (3r)-hydroxyacyl-acp dehydratase enzymes involved in the biosynthesis of mycolic acids and use of same for screening antibiotics |
12/31/2008 | WO2008126065A3 Polynucleotides and polypeptides involved in gestational malaria, and biological applications |
12/31/2008 | WO2008125983A3 Methods of increasing plant growth |
12/31/2008 | WO2008112613A9 Manipulation of ammonium transporters (amts) to improve nitrogen use efficiency in higher plants |
12/31/2008 | WO2008112290A3 Use of ephb4 as a diagnostic marker and a therapeutic target for ovarian cancer |
12/31/2008 | WO2008112019A3 Maize event dp-098140-6 and compositions and methods for the identification and/or detection thereof |
12/31/2008 | WO2008109555B1 Nucleic acid compounds for inhibiting nrg1 gene expression and uses thereof |
12/31/2008 | WO2008109555A4 Nucleic acid compounds for inhibiting nrg1 gene expression and uses thereof |
12/31/2008 | WO2008109493B1 Nucleic acid compounds for inhibiting cd19 gene expression and uses thereof |
12/31/2008 | WO2008109493A4 Nucleic acid compounds for inhibiting cd19 gene expression and uses thereof |
12/31/2008 | WO2008109379A9 Nucleic acid compounds for inhibiting il17a gene expression and uses thereof |
12/31/2008 | WO2008109377A9 Nucleic acid compounds for inhibiting vegf family gene expression and uses thereof |
12/31/2008 | WO2008109364B1 Nucleic acid compounds for inhibiting frap1 gene expression and uses thereof |
12/31/2008 | WO2008109364A4 Nucleic acid compounds for inhibiting frap1 gene expression and uses thereof |
12/31/2008 | WO2008106984A3 Pig model for breast cancer, mitochondria related protein folding disorders and/or epidermolysis bullosa simplex |
12/31/2008 | WO2008106982A3 Pig model for atherosclerosis |
12/31/2008 | WO2008103751A3 Antimicrobial and anti-inflammatory therapies and compositions |
12/31/2008 | WO2008101216A3 Gamma satellite insulator sequences and their use in preventing gene silencing |
12/31/2008 | WO2008097585A3 Mutations in human ubiad1 |
12/31/2008 | WO2008093010A3 Method for the random diversification of a genetic sequence while preserving the identity of some inner segments of said genetic sequence |
12/31/2008 | WO2008089061A3 Acetyl-coa carboxylase herbicide resistant sorghum |
12/31/2008 | WO2008079545A3 Generation of plants with altered protein, fiber, or oil content |
12/31/2008 | WO2008061157A3 Generation of plants with altered protein, fiber, or oil content |
12/31/2008 | WO2008044068A3 Combination therapy |
12/31/2008 | WO2008039980A3 Apoptotic cell-mediated transfection of mammalian cells with interfering rna |
12/31/2008 | WO2008036392A3 Genetically programmed expression of selectively sulfated proteins in eubacteria |
12/31/2008 | WO2008005889A3 Tetanus toxin fragment c based imaging agents and methods, and confocal microscopy dataset processes |
12/31/2008 | WO2007120842A3 Methods and compositions for targeting c-rel |
12/31/2008 | WO2007119011A9 N protein fusion proteins of a virus in the paramyxoviridae-protein of interest family |
12/31/2008 | WO2007119011A8 N protein fusion proteins of a virus in the paramyxoviridae-protein of interest family |
12/31/2008 | WO2007087420A3 Production of proteins carrying oligomannose or human-like glycans in yeast and methods of use thereof |
12/31/2008 | WO2007084631A3 Translocation and mutant ros kinase in human non-small cell lung carcinoma |
12/31/2008 | WO2007075933A3 Translocation and mutant csf1r kinase in human leukemia |
12/31/2008 | WO2007005604A3 Polynucleotides encoding isoprenoid modifying enzymes and methods of use thereof |
12/31/2008 | WO2005055704A3 Wheat having reduced waxy protein due to non-transgenic alterations of a waxy gene |
12/31/2008 | EP2009443A1 Diagnostic agent and therapeutic agent for pancreatic cancer |
12/31/2008 | EP2009109A1 G protein-related kinase mutants in essential hypertension |
12/31/2008 | EP2009108A1 Starches with high amylose content and improved processing characteristics |
12/31/2008 | EP2009107A2 Thermotolerant ribonuclease H |
12/31/2008 | EP2009106A2 Cloning and expression of cDNA for human dihydropyrimidine dehydrogenase |
12/31/2008 | EP2009105A1 Novel serotype Streptococcus mutans and utilization of the same |
12/31/2008 | EP2009104A1 Phosphorylation epitopes of Tau protein for the diagnosis and treatment of Alzheimer's disease |
12/31/2008 | EP2009103A1 Neurotrophic peptides |
12/31/2008 | EP2009102A2 Random mutagenesis and amplification of nucleic acid |
12/31/2008 | EP2009101A1 Antibody modification method for purifying bispecific antibody |
12/31/2008 | EP2009100A1 siRNA SPECIFIC TO WT1 17AA(-)ISOFORM AND USE THEREOF |